Discovery of Novel c-Jun N-Terminal Kinase 1 Inhibitors from Natural Products: Integrating Artificial Intelligence with Structure-Based Virtual Screening and Biological Evaluation

c-Jun N-terminal kinase 1 (JNK1) is currently considered a critical therapeutic target for type-2 diabetes. In recent years, there has been a great interest in naturopathic molecules, and the discovery of active ingredients from natural products for specific targets has received increasing attention...

Descripción completa

Detalles Bibliográficos
Autores principales: Yang, Ruoqi, Zhao, Guiping, Yan, Bin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9572546/
https://www.ncbi.nlm.nih.gov/pubmed/36234788
http://dx.doi.org/10.3390/molecules27196249

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9572546/
https://www.ncbi.nlm.nih.gov/pubmed/36234788
http://dx.doi.org/10.3390/molecules27196249

Ejemplares similares